North Star Investment Management’s Editas Medicine EDIT Stock Holding History

North Star Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$94	Hold	38	–	–	﹤0.01%	1690
2025 Q4	$78	Hold	38	–	–	﹤0.01%	1560
2025 Q3	$132	Hold	38	–	–	﹤0.01%	1298
2025 Q2	$84	Hold	38	–	–	﹤0.01%	1197
2025 Q1	$44	Hold	38	–	–	﹤0.01%	1188
2024 Q4	$48	Hold	38	–	–	﹤0.01%	1206
2024 Q3	$130	Hold	38	–	–	﹤0.01%	1157
2024 Q2	$177	Hold	38	–	–	﹤0.01%	1130
2024 Q1	$282	Hold	38	–	–	﹤0.01%	1194
2023 Q4	$385	Hold	38	–	–	﹤0.01%	1145
2023 Q3	$296	Hold	38	–	–	﹤0.01%	1229
2023 Q2	$313	Hold	38	–	–	﹤0.01%	1242
2023 Q1	$276	Hold	38	–	–	﹤0.01%	1260
2022 Q4	$337	Hold	38	–	–	﹤0.01%	1257
2022 Q3	$0	Hold	38	–	–	﹤0.01%	1142
2022 Q2	$0	Hold	38	–	–	﹤0.01%	1145
2022 Q1	$1K	Hold	38	–	–	﹤0.01%	1093
2021 Q4	$1K	Hold	38	–	–	﹤0.01%	1121
2021 Q3	$2K	Hold	38	–	–	﹤0.01%	1033
2021 Q2	$2K	Hold	38	–	–	﹤0.01%	1013
2021 Q1	$2K	Hold	38	–	–	﹤0.01%	970
2020 Q4	$3K	Buy	+38	New	+$1.56K	﹤0.01%	914
2016 Q3	–	Sell	-200	Closed	-$5K	–	800
2016 Q2	$5K	Buy	+200	New	+$6.75K	﹤0.01%	693

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

North Star Investment Management's EDIT Position: Q1 2026 in Review

North Star Investment Management held its Editas Medicine (EDIT) position steady in Q1 2026 at 38 shares worth $94. The position accounts for ﹤0.01% of the portfolio, ranked #1690.

North Star Investment Management first reported a position in EDIT in Q2 2016 and has held it in 23 quarters since. The position peaked at $5K in Q2 2016. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

North Star Investment Management held 38 shares of Editas Medicine worth $94 as of Q1 2026.
North Star Investment Management left its Editas Medicine share count unchanged in Q1 2026.
Editas Medicine made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #1690 holding.
North Star Investment Management first reported a position in Editas Medicine in Q2 2016 and has held it in 23 quarters since.
North Star Investment Management's Editas Medicine position peaked at $5K in Q2 2016.
207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.